IMPRINT sponsors three successful candidates to attend the GCRF Networks Vaccinology Course in Bangkok

October 1, 2018

By

Share

Congratulations to Dr Lok Bahadur Shrestha, assistant professor at the B. P. Koirala Institute of Health Sciences (BPKIHS), Dharan, Nepal; Nasamon Wanlapakorn from Thailand, currently pursuing her PhD at the Institute of Infection and Global Health at the University of Liverpool, UK and Dr Shona Moore, Postdoctoral Research Assistant at the University of Liverpool, Institute of Infection and Global Health, UK. They successfully applied for IMPRINT scholarships to attend the GCRF Networks Vaccinology Course in Bangkok.

The 5 day workshop on veterinary and human vaccinology is run by the GCRF Networks in Vaccines Research and Development (IVVN, BactiVac, HIC-Vac, IMPRINT, and VALIDATE) in association with the United Nations Food and Agriculture Organisation (UN FAO), through the European Commission for the Control of Foot and Mouth Disease (EuFMD), from Monday 3rd through Friday 7th December 2018 in Bangkok, Thailand. The course, aimed at post-graduate students and early career researchers, addresses aspects of human and animal vaccinology, the vaccine development process, biomanufacturing, regulatory and ethical issues. The course will be delivered by an exceptional line up of world renowned academic and industrial speakers and resonates with the ‘One Health’ agenda by highlighting the synergies between the human and veterinary vaccinology fields from scientific, technological and regulatory perspectives. The course emulates the successful series of Jenner Institute training courses in Africa.

Congratulations to all of them!

Sign up for our membership, and receive news about current IMPRINT and external funding opportunities. For more information click here: GCRF Networks Vaccinology Course

Share:

You might also like to read

April 15, 2020

Survey on Routine Immunisations in Times of COVID-19

The IMPRINT network has developed a survey for monitoring how immunisation efforts for pregnant women, newborns and infants are impacted by the COVID-19 pandemic.